Treatment selection in metastatic renal cell carcinoma: expert consensus
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment selection in metastatic renal cell carcinoma: expert consensus
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 9, Issue 6, Pages 327-337
Publisher
Springer Nature
Online
2012-04-10
DOI
10.1038/nrclinonc.2012.59
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The high-dose aldesleukin (HD IL-2) “SELECT” trial in patients with metastatic renal cell carcinoma (mRCC).
- (2017) D. F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib in papillary renal cell carcinoma (pRCC): Results from a single-arm phase II study.
- (2017) E. R. Plimack et al. JOURNAL OF CLINICAL ONCOLOGY
- AMG 386 in combination with sorafenib in patients (pts) with metastatic renal cell cancer (mRCC): A randomized, double-blind, placebo-controlled, phase II study.
- (2017) B. I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- BEVLiN: Prospective study of the safety and efficacy of first-line bevacizumab (BEV) plus low-dose interferon-α2a (IFN) in patients (pts) with metastatic renal cell carcinoma (mRCC).
- (2017) B. Melichar et al. JOURNAL OF CLINICAL ONCOLOGY
- External validation of the International Metastatic Renal Cell Carcinoma (mRCC) Database Consortium prognostic model and comparison to four other models in the era of targeted therapy.
- (2017) D. Y. C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of two major prognostic models for patients with metastatic renal cell carcinoma treated in the contemporary era of targeted therapies.
- (2017) M. Crepel et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and Safety of Everolimus in Elderly Patients With Metastatic Renal Cell Carcinoma: An Exploratory Analysis of the Outcomes of Elderly Patients in the RECORD-1 Trial
- (2012) Camillo Porta et al. EUROPEAN UROLOGY
- Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma--data from the Czech registry
- (2011) T. Buchler et al. ANNALS OF ONCOLOGY
- Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings
- (2011) J. Beck et al. ANNALS OF ONCOLOGY
- Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases
- (2011) Camillo Porta et al. BJU INTERNATIONAL
- Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial
- (2011) G Procopio et al. BRITISH JOURNAL OF CANCER
- Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
- (2011) Judith Manola et al. CLINICAL CANCER RESEARCH
- 7153 POSTER Treatment (trx) Modalities After a Front Line Targeted Therapies in Patients (pts) With Metastatic Renal Cell Carcinoma (mRCC)
- (2011) A. Levy et al. EUROPEAN JOURNAL OF CANCER
- Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions
- (2011) Simon Chowdhury et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Primary Intracranial Leiomyosarcoma in an Immunocompetent Adult
- (2011) Narothama Reddy Aeddula et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimizing Therapy and Maximizing Outcomes in Rectal Cancer
- (2011) Joel E. Tepper et al. JOURNAL OF CLINICAL ONCOLOGY
- S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma
- (2011) Lawrence P. Leichman et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus- and Temsirolimus-Associated Enteritis: Report of Three Cases
- (2011) Kavitha Parithivel et al. JOURNAL OF CLINICAL ONCOLOGY
- Necrobiotic Xanthogranuloma Associated With Immunoglobulin M Paraproteinemia in a Patient With Waldenström Macroglobulinemia
- (2011) Yevgeniy Balagula et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Evaluation of Tumoral Response to Antiangiogenic Therapy by Arterial Spin Labeling Perfusion Magnetic Resonance Imaging and Susceptibility Weighted Imaging in a Patient With Recurrent Glioblastoma Receiving Bevacizumab
- (2011) Slim Fellah et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
- (2011) Sylvie Négrier et al. LANCET ONCOLOGY
- Initial Patterns of Care With Oral Targeted Therapies for Patients With Renal Cell Carcinoma
- (2011) Christopher P. Filson et al. UROLOGY
- A Phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)
- (2010) Viktor Grünwald et al. ACTA ONCOLOGICA
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) B. Escudier et al. ANNALS OF ONCOLOGY
- Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial
- (2010) Jorge A. Garcia et al. BJU INTERNATIONAL
- Sunitinib rechallenge in metastatic renal cell carcinoma patients
- (2010) Ivan N. Zama et al. CANCER
- Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
- (2010) Walter M. Stadler et al. CANCER
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
- (2010) Anthony W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis
- (2010) Maxine Sun et al. EUROPEAN UROLOGY
- Expert opinion on the use of first-line sorafenib in selected metastatic renal cell carcinoma patients
- (2010) Joaquim Bellmunt et al. Expert Review of Anticancer Therapy
- Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
- (2010) Ana M. Molina et al. INVESTIGATIONAL NEW DRUGS
- Kidney Cancer Working Group Report
- (2010) S. Naito et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review
- (2009) Toni K. Choueiri et al. BJU INTERNATIONAL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. Clinical Genitourinary Cancer
- Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients
- (2009) Sei Naito et al. EUROPEAN UROLOGY
- 142 ELDERLY PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC)SUCCESSFULLY TREATED
- (2009) S. Bracarda et al. EUROPEAN UROLOGY SUPPLEMENTS
- Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer
- (2009) Axel S Merseburger et al. Expert Review of Anticancer Therapy
- Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma
- (2009) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
- (2009) M.P. Sablin et al. JOURNAL OF UROLOGY
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
- (2009) Martin E Gore et al. LANCET ONCOLOGY
- Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
- (2009) Janice P. Dutcher et al. MEDICAL ONCOLOGY
- Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib
- (2009) Kaja Zimmermann et al. ONCOLOGY
- Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
- (2008) Arkadiusz Z. Dudek et al. CANCER
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
- Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
- (2008) Christian Eichelberg et al. EUROPEAN UROLOGY
- Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma
- (2008) Guru Sonpavde et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Axitinib for renal cell carcinoma
- (2008) Guru Sonpavde et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial
- (2008) T. Eisen et al. JNCI-Journal of the National Cancer Institute
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Effects of Sunitinib or Sorafenib in Patients With Metastatic Renal Cell Carcinoma Who Received Prior Antiangiogenic Therapy
- (2007) Ila Tamaskar et al. JOURNAL OF UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started